These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 20471507)
1. Basal bone phenotype and increased anabolic responses to intermittent parathyroid hormone in healthy male COX-2 knockout mice. Xu M; Choudhary S; Voznesensky O; Gao Q; Adams D; Diaz-Doran V; Wu Q; Goltzman D; Raisz LG; Pilbeam CC Bone; 2010 Aug; 47(2):341-52. PubMed ID: 20471507 [TBL] [Abstract][Full Text] [Related]
2. Cyclooxygenase-2 suppresses the anabolic response to PTH infusion in mice. Choudhary S; Canalis E; Estus T; Adams D; Pilbeam C PLoS One; 2015; 10(3):e0120164. PubMed ID: 25781979 [TBL] [Abstract][Full Text] [Related]
3. Accentuated osteoclastic response to parathyroid hormone undermines bone mass acquisition in osteonectin-null mice. Machado do Reis L; Kessler CB; Adams DJ; Lorenzo J; Jorgetti V; Delany AM Bone; 2008 Aug; 43(2):264-273. PubMed ID: 18499553 [TBL] [Abstract][Full Text] [Related]
4. Do cyclooxygenase-2 knockout mice have primary hyperparathyroidism? Xu M; Choudhary S; Goltzman D; Ledgard F; Adams D; Gronowicz G; Koczon-Jaremko B; Raisz L; Pilbeam C Endocrinology; 2005 Apr; 146(4):1843-53. PubMed ID: 15625247 [TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E2 acts via bone marrow macrophages to block PTH-stimulated osteoblast differentiation in vitro. Choudhary S; Blackwell K; Voznesensky O; Deb Roy A; Pilbeam C Bone; 2013 Sep; 56(1):31-41. PubMed ID: 23639875 [TBL] [Abstract][Full Text] [Related]
6. Bone response to intermittent parathyroid hormone is altered in mice null for {beta}-Arrestin2. Ferrari SL; Pierroz DD; Glatt V; Goddard DS; Bianchi EN; Lin FT; Manen D; Bouxsein ML Endocrinology; 2005 Apr; 146(4):1854-62. PubMed ID: 15705780 [TBL] [Abstract][Full Text] [Related]
7. Anabolic effects of PTH in cyclooxygenase-2 knockout osteoblasts in vitro. Choudhary S; Huang H; Raisz L; Pilbeam C Biochem Biophys Res Commun; 2008 Aug; 372(4):536-41. PubMed ID: 18501188 [TBL] [Abstract][Full Text] [Related]
8. Sustained RANKL response to parathyroid hormone in oncostatin M receptor-deficient osteoblasts converts anabolic treatment to a catabolic effect in vivo. Walker EC; Poulton IJ; McGregor NE; Ho PW; Allan EH; Quach JM; Martin TJ; Sims NA J Bone Miner Res; 2012 Apr; 27(4):902-12. PubMed ID: 22190112 [TBL] [Abstract][Full Text] [Related]
9. CREM deficiency in mice alters the response of bone to intermittent parathyroid hormone treatment. Liu F; Lee SK; Adams DJ; Gronowicz GA; Kream BE Bone; 2007 Apr; 40(4):1135-43. PubMed ID: 17275432 [TBL] [Abstract][Full Text] [Related]
10. Disruption of LRP6 in osteoblasts blunts the bone anabolic activity of PTH. Li C; Xing Q; Yu B; Xie H; Wang W; Shi C; Crane JL; Cao X; Wan M J Bone Miner Res; 2013 Oct; 28(10):2094-108. PubMed ID: 23609180 [TBL] [Abstract][Full Text] [Related]
11. Pregnancy-associated plasma protein-A modulates the anabolic effects of parathyroid hormone in mouse bone. Clifton KB; Conover CA Bone; 2015 Dec; 81():413-416. PubMed ID: 26297833 [TBL] [Abstract][Full Text] [Related]
12. beta-Arrestin2 regulates the differential response of cortical and trabecular bone to intermittent PTH in female mice. Bouxsein ML; Pierroz DD; Glatt V; Goddard DS; Cavat F; Rizzoli R; Ferrari SL J Bone Miner Res; 2005 Apr; 20(4):635-43. PubMed ID: 15765183 [TBL] [Abstract][Full Text] [Related]
15. Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice. Iida-Klein A; Zhou H; Lu SS; Levine LR; Ducayen-Knowles M; Dempster DW; Nieves J; Lindsay R J Bone Miner Res; 2002 May; 17(5):808-16. PubMed ID: 12009011 [TBL] [Abstract][Full Text] [Related]
16. Disruption of the aldehyde dehydrogenase 2 gene increases the bone anabolic response to intermittent PTH treatment in an ovariectomized mouse model. Kosugi K; Tajima T; Menuki K; Okuma KF; Tokuda K; Fukuda H; Okada Y; Tsukamoto M; Yamanaka Y; Zenke Y; Sakai A Bone; 2020 Jul; 136():115370. PubMed ID: 32325250 [TBL] [Abstract][Full Text] [Related]
17. Mice lacking bone sialoprotein (BSP) lose bone after ovariectomy and display skeletal site-specific response to intermittent PTH treatment. Wade-Gueye NM; Boudiffa M; Laroche N; Vanden-Bossche A; Fournier C; Aubin JE; Vico L; Lafage-Proust MH; Malaval L Endocrinology; 2010 Nov; 151(11):5103-13. PubMed ID: 20844009 [TBL] [Abstract][Full Text] [Related]
18. Contributions of parathyroid hormone (PTH)/PTH-related peptide receptor signaling pathways to the anabolic effect of PTH on bone. Yang D; Singh R; Divieti P; Guo J; Bouxsein ML; Bringhurst FR Bone; 2007 Jun; 40(6):1453-61. PubMed ID: 17376756 [TBL] [Abstract][Full Text] [Related]
19. Continuous PTH in Male Mice Causes Bone Loss Because It Induces Serum Amyloid A. Choudhary S; Santone E; Yee SP; Lorenzo J; Adams DJ; Goetjen A; McCarthy MB; Mazzocca AD; Pilbeam C Endocrinology; 2018 Jul; 159(7):2759-2776. PubMed ID: 29757436 [TBL] [Abstract][Full Text] [Related]
20. Beta-Arrestin2 regulates RANKL and ephrins gene expression in response to bone remodeling in mice. Pierroz DD; Rufo A; Bianchi EN; Glatt V; Capulli M; Rucci N; Cavat F; Rizzoli R; Teti A; Bouxsein ML; Ferrari SL J Bone Miner Res; 2009 May; 24(5):775-84. PubMed ID: 19113915 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]